The next board meeting for Adaptimmune Therapeutics Plc - ADR is on 20 Mar 2025 for the purpose of Adaptimmune Therapeutics PLC Fourth Quarter Earnings Result for 2024See details
Adaptimmune Therapeutics Plc - ADR has a share price target of US$ 2, revenue growth forecast of 203.9%, and profit growth estimate of 63.4% for FY24, based on top 8 analyst calls.